MDC1 maintains active elongation complexes of RNA polymerase II.

Cell Rep

Genome Integrity Group, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark; Department of Medical Biochemistry and Biophysics, Division of Genome Biology, Karolinska Institutet, Science for Life Laboratory, 17177 Stockholm, Sweden. Electronic address:

Published: January 2023

The role of MDC1 in the DNA damage response has been extensively studied; however, its impact on other cellular processes is not well understood. Here, we describe the role of MDC1 in transcription as a regulator of RNA polymerase II (RNAPII). Depletion of MDC1 causes a genome-wide reduction in the abundance of actively engaged RNAPII elongation complexes throughout the gene body of protein-encoding genes under unperturbed conditions. Decreased engaged RNAPII subsequently alters the assembly of the spliceosome complex on chromatin, leading to changes in pre-mRNA splicing. Mechanistically, the S/TQ domain of MDC1 modulates RNAPII-mediated transcription. Upon genotoxic stress, MDC1 promotes the abundance of engaged RNAPII complexes at DNA breaks, thereby stimulating nascent transcription at the damaged sites. Of clinical relevance, cancer cells lacking MDC1 display hypersensitivity to RNAPII inhibitors. Overall, we unveil a role of MDC1 in RNAPII-mediated transcription with potential implications for cancer treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2022.111979DOI Listing

Publication Analysis

Top Keywords

role mdc1
12
engaged rnapii
12
mdc1
8
elongation complexes
8
rna polymerase
8
rnapii-mediated transcription
8
rnapii
5
mdc1 maintains
4
maintains active
4
active elongation
4

Similar Publications

Article Synopsis
  • Breast cancer is the leading cancer-related cause of death in women, highlighting the urgent need for new treatment strategies.
  • Recent research suggests that reactivating Tumor Suppressor Genes (TSGs) could be a promising intervention by understanding their defects and identifying those under positive selection in mammalian genomes.
  • The study identified critical positively selected sites in TSGs like BRCA1 and BRCA2, which are vital for DNA repair, and has developed an automated tool to aid future research on these genetic targets.
View Article and Find Full Text PDF

Meiosis in males is a critical process that ensures complete spermatogenesis and genetic diversity. However, the key regulators involved in this process and the underlying molecular mechanisms remain unclear. Here, we report an essential role of the mA methyltransferase METTL16 in meiotic sex chromosome inactivation (MSCI), double-strand break (DSB) formation, homologous recombination and SYCP1 deposition during male meiosis.

View Article and Find Full Text PDF
Article Synopsis
  • VGLL3 is identified as a key player in the DNA damage response (DDR), which helps cells repair damaged DNA.
  • Decreasing VGLL3 levels leads to reduced repair efficiency, making cells more sensitive to chemotherapy while delaying tumor growth.
  • The study also reveals that VGLL3 stabilizes certain proteins involved in DNA repair by preventing their degradation, highlighting a unique function separate from its role in regulating gene transcription.
View Article and Find Full Text PDF

A new role for human papillomavirus 16 E2: Mitotic activation of the DNA damage response to promote viral genome segregation.

Tumour Virus Res

December 2024

Virginia Commonwealth University (VCU), Philips Institute for Oral Health Research, School of Dentistry, Richmond, VA, 23298, USA; VCU Massey Cancer Center, Richmond, VA, 23298, USA. Electronic address:

Human papillomaviruses (HPV) are causative agents in around 5% of all human cancers. To identify and develop new targeted HPV therapeutics we must enhance our understanding of the viral life cycle and how it interacts with the host. The HPV E2 protein dimerizes and binds to 12bp target sequences in the viral genome and segregates the viral genome during mitosis.

View Article and Find Full Text PDF

DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer.

Anticancer Res

May 2024

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Article Synopsis
  • The study investigates the role of the DNA checkpoint (DNACHK) pathway in cancer immunotherapy, focusing on its effects on patients with advanced biliary tract cancers treated with immune checkpoint inhibitors (ICIs).
  • A total of 62 patients were analyzed, with 40.3% having mutations in the DNACHK pathway, while the remaining were wild-type; key mutations included alterations in genes like ATM and TP53BP1.
  • Results suggest that patients with DNACHK mutations had a slightly better disease control rate and overall survival compared to the wild-type group, indicating the potential of DNACHK as a biomarker for ICI response.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!